Inventor · disambiguated record
Rachel Humphrey
Also filed as: HUMPHREY RACHEL W · HUMPHREY RACHEL WALLACH · Humphrey Rachel
1 granted patent·10 pending applications·2 citations·filing 2002–2021
20Inventor score
Top patents by PatentIndex Score
11 records- 0170US11168144B2Activatable anti-PDL1 antibodies, and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2018·Granted Nov 9, 2021·2 cites·39 claims
- 0259US2006247186A1Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancersCARTER CHRISTOPHER A·Filed 2006·Application pending·0 cites
- 0354US2003232765A1Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancersBAYER AG·Filed 2002·Application pending·0 cites
- 0452US2019117789A1Activatable anti-cd166 antibodies and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0552US2012040925A1Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancersCARTER CHRISTOPHER A·Filed 2011·Application pending·0 cites
- 0652US2021100913A1Activatable anti-cd166 antibodies and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0748US2022162332A1Activatable anti-pdl1 antibodies, and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0846US2022023439A1Activatable anti-cd166 antibodies and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0936US2022306745A1Use of an activatable anti-pdl1 antibody and an anti-ctla-4 antibody in a combination therapy for the treatment of cancerCYTOMX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1036US2022296692A1Use of an activatable anti-pdl1 antibody and an anti-ctla-4 antibody in a neoadjuvant combination therapy for the treatment of cancerCYTOMX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1123US2013064831A1Immunotherapeutic dosing regimens and combinations thereofHUMPHREY RACHEL WALLACH·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rachel Humphrey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →